Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Parashar
    Junior Member
    • Feb 2014
    • 5

    #1

    Bacterial Resequencing: Single Nucleotide Variants

    We have sequenced clonal populations of 20 bacterial lines.
    Sequencing was done on Illumina platform in two batches.

    For the first run, 10 lines were chosen and each was sequenced at 40x coverage
    In the second run , the other 10 lines were sequenced at 150x coverage.

    Now, I performed SNV detection in these 20 samples, using three different tools, BRESEQ, MAQ and VARSCAN. Each line was compared against a near isogenic E.Coli reference.

    Now the issue in hand is:
    While in lines sequenced at 40x, SNV are detected at 100% frequency. In other words, whenever a variant is detected in a particular line, it has 100% frequency. Hence its a binary form, either the line has a SNV at 100% frequency or it doesn't.

    But, this is not the case with high coverage (>150x) samples. Here, what I see a lot of marginal predictions for variants, i.e variants called have a frequency ranging from 10% to 99 %.

    This is surprising, because in a single sample, the bacteria are clonal and hence chances of multiple variants are very low.

    I have checked the mapping quality of reads in the pileup and it looks good.

    Any suggestions will be highly appreciated.
  • Nikvailo
    Member
    • Apr 2013
    • 15

    #2
    Possibly this problem is due to contamination. The contamination can be in DNA isolation on can be on-instrument. Any remaining DNA may result that kind of problems. I suggest extra washes between runs.

    I just want ask small question. Are the low frequency variants also seen in previous samples (which are 40x)?

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    38 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    44 views
    0 reactions
    Last Post SEQadmin2  
    Working...